Circulating endothelial progenitor cells: Do they live up to their name?

Vascular Pharmacology

Volumn 67, Issue , 2015, Pages 2-5

  Madonna, Rosalinda ^a   De Caterina, Raffaele ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Atherosclerosis; Biomarker; Endothelial progenitor cells; Neovascularization; Tissue ischemia

Indexed keywords

BIOLOGICAL MARKER;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ANGINA PECTORIS; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CAPILLARY ENDOTHELIAL CELL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY DISEASE; CORONARY FLOW RESERVE; DISEASE ACTIVITY; ENDOTHELIAL PROGENITOR CELL; EX VIVO STUDY; HEART FUNCTION; HEART LEFT VENTRICLE FUNCTION; HEMATOPOIETIC STEM CELL; HUMAN; ISCHEMIC HEART DISEASE; LIMB ISCHEMIA; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PARACRINE SIGNALING; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; SURGERY; TISSUE INJURY; TISSUE REGENERATION; ANIMAL; BLOOD; CARDIOVASCULAR DISEASES; CELL CULTURE TECHNIQUE; CYTOLOGY; METABOLISM; PROCEDURES; TRANSPLANTATION; VASCULAR ENDOTHELIUM;

ANIMALS; ATHEROSCLEROSIS; BIOMARKERS; CARDIOVASCULAR DISEASES; CELL CULTURE TECHNIQUES; ENDOTHELIAL PROGENITOR CELLS; ENDOTHELIUM, VASCULAR; HUMANS;

EID: 84929266213     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2015.02.018     Document Type: Review

References (34)

1. Rafii S., Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat. Med. 2003, 9:702-712.
2. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
3. Aoki M., Yasutake M., Murohara T. Derivation of functional endothelial progenitor cells from human umbilical cord blood mononuclear cells isolated by a novel cell filtration device. Stem Cells 2004, 22:994-1002.
4. Hagensen M.K., Shim J., Thim T., Falk E., Bentzon J.F. Circulating endothelial progenitor cells do not contribute to plaque endothelium in murine atherosclerosis. Circulation 2010, 121:898-905.
5. Vasa M., Fichtlscherer S., Aicher A., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ. Res. 2001, 89:E1-E7.
6. Schmidt-Lucke C., Rossig L., Fichtlscherer S., et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005, 111:2981-2987.
7. Tepper O.M., Galiano R.D., Capla J.M., et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002, 106:2781-2786.
8. Abdel-Latif A., Bolli R., Tleyjeh I.M., et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch. Intern. Med. 2007, 167:989-997.
9. Fadini G.P., Rigato M., Boscari F., et al. Short-term statin discontinuation increases endothelial progenitor cells without inflammatory rebound in type 2 diabetic patients. Vascul. Pharmacol. 2014.
10. Rafii S. Circulating endothelial precursors: mystery, reality, and promise. J. Clin. Invest. 2000, 105:17-19.
11. Peichev M., Naiyer A.J., Pereira D., et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000, 95:952-958.
12. Case J., Mead L.E., Bessler W.K., et al. Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp. Hematol. 2007, 35:1109-1118.
13. Hill J.M., Zalos G., Halcox J.P., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 2003, 348:593-600.
14. Rehman J., Li J., Orschell C.M., March K.L. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003, 107:1164-1169.
15. Richardson M.R., Yoder M.C. Endothelial progenitor cells: quo vadis?. J. Mol. Cell. Cardiol. 2010, 50:266-272.
16. Rohde E., Malischnik C., Thaler D., et al. Blood monocytes mimic endothelial progenitor cells. Stem Cells 2006, 24:357-367.
17. Urbich C., Heeschen C., Aicher A., Dernbach E., Zeiher A.M., Dimmeler S. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 2003, 108:2511-2516.
18. Schnabel R.B., Schulz A., Messow C.M., et al. Multiple marker approach to risk stratification in patients with stable coronary artery disease. Eur. Heart J. 2010, 31:3024-3031.
19. Shintani S., Murohara T., Ikeda H., et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001, 103:2776-2779.
20. Hristov M., Fach C., Becker C., et al. Reduced numbers of circulating endothelial progenitor cells in patients with coronary artery disease associated with long-term statin treatment. Atherosclerosis 2007, 192:413-420.
21. Werner N., Kosiol S., Schiegl T., et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N. Engl. J. Med. 2005, 353:999-1007.
22. Reinisch A., Hofmann N.A., Obenauf A.C., et al. Humanized large-scale expanded endothelial colony-forming cells function in vitro and in vivo. Blood 2009, 113:6716-6725.
23. Meneveau N., Deschaseaux F., Seronde M.F., et al. Presence of endothelial colony-forming cells is associated with reduced microvascular obstruction limiting infarct size and left ventricular remodelling in patients with acute myocardial infarction. Basic Res. Cardiol. 2011, 106:1397-1410.
24. Newey S.E., Tsaknakis G., Khoo C.P., et al. The hematopoietic chemokine CXCL12 promotes integration of human endothelial colony forming cell-derived cells into immature vessel networks. Stem Cells Dev. 2014, 23:2730-2743.
25. Chang Z.T., Hong L., Wang H., Lai H.L., Li L.F., Yin Q.L. Application of peripheral-blood-derived endothelial progenitor cell for treating ischemia-reperfusion injury and infarction: a preclinical study in rat models. J. Cardiothorac. Surg. 2013, 8:33.
26. Zhang S., Zhao L., Shen L., et al. Comparison of various niches for endothelial progenitor cell therapy on ischemic myocardial repair: coexistence of host collateralization and Akt-mediated angiogenesis produces a superior microenvironment. Arterioscler. Thromb. Vasc. Biol. 2012, 32:910-923.
27. Raval Z., Losordo D.W. Cell therapy of peripheral arterial disease: from experimental findings to clinical trials. Circ. Res. 2013, 112:1288-1302.
28. Tongers J., Roncalli J.G., Losordo D.W. Role of endothelial progenitor cells during ischemia-induced vasculogenesis and collateral formation. Microvasc. Res. 2010, 79:200-206.
29. Hoffmann B.R., Wagner J.R., Prisco A.R., Janiak A., Greene A.S. Vascular endothelial growth factor-A signaling in bone marrow-derived endothelial progenitor cells exposed to hypoxic stress. Physiol. Genomics 2013, 45:1021-1034.
30. Barcelos L.S., Duplaa C., Kränkel N., et al. Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling. Circ. Res. 2009, 104:1095-1102.
31. Urbich C., Aicher A., Heeschen C., et al. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J. Mol. Cell. Cardiol. 2005, 39:733-742.
32. Huang B., Cheng Y., Xie Q., et al. Effect of 40mg versus 10mg of atorvastatin on oxidized low-density lipoprotein, high-sensitivity C-reactive protein, circulating endothelial-derived microparticles, and endothelial progenitor cells in patients with ischemic cardiomyopathy. Clin. Cardiol. 2012, 35:125-130.
33. Wang W., Lang J.K., Suzuki G., Canty J.M., Cimato T. Statins enhance clonal growth of late outgrowth endothelial progenitors and increase myocardial capillary density in the chronically ischemic heart. PLoS One 2011, 6:e24868.
34. Werner N., Priller J., Laufs U., et al. Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition. Arterioscler. Thromb. Vasc. Biol. 2002, 22:1567-1572.